Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | S100A9 |
| Upstream (Parents) |
|---|
| (<<) APOBEC3A → S100A9 |
| (<<) FCGR3B → S100A9 |
| (<<) MNDA → S100A9 |
| (<<) S100A8 → S100A9 |
| (<<) FAM65B → S100A9 |
| Downstream (Children) |
|---|
| S100A9 → APOBEC3A (>>) |
| S100A9 → CRNN (>>) |
| S100A9 → CPA4 (>>) |
| S100A9 → MAL (>>) |
| S100A9 → TRIM58 (>>) |
| S100A9 → CLCA2 (>>) |
| S100A9 → DGKB (>>) |
| S100A9 → S100A8 (>>) |
| S100A9 → SERPINB4///SERPINB3 (>>) |
| S100A9 → EMR3 (>>) |
| S100A9 → S100A12 (>>) |
| S100A9 → KCNJ15 (>>) |
| S100A9 → D4S234E (>>) |
